CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Tada Hiroomi Chief Medical Officer | Grant or award | +1,968 | $6.58 | $13K | 86,435 |
| 2024-03-15 | Harris Todd President and CEO | Grant or award | +1,880 | $6.58 | $12K | 1,504,577 |
| 2024-03-11 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −200 | $20.00 | $4K | 431,683 |
| 2024-03-07 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −68 | $20.00 | $1K | 431,883 |
| 2024-03-06 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,733 | $20.09 | $35K | 431,951 |
| 2024-03-05 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,189 | $20.02 | $24K | 433,684 |
| 2024-03-04 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −5,063 | $20.08 | $102K | 434,873 |
| 2024-03-01 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −2,900 | $20.04 | $58K | 439,936 |
| 2024-02-29 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −2,050 | $20.00 | $41K | 442,836 |
| 2024-02-28 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −5,849 | $20.13 | $118K | 444,886 |
| 2024-02-27 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −745 | $20.00 | $15K | 450,735 |
| 2024-02-12 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,501 | $20.00 | $30K | 451,480 |
| 2024-02-07 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −9,587 | $18.09 | $173K | 452,981 |
| 2024-02-06 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +3,180,155 | $13.01 | $41.4M | 8,477,275 |
| 2024-02-06 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Pre-Funded Warrants (Right to Buy) | +1,538,457 | $13.01 | $20.0M | 1,538,457 |
| 2024-02-06 | Boxer Capital, LLC See Remarks | Grant or award | +63,412 | $13.01 | $825K | 85,939 |
| 2024-02-06 | Boxer Capital, LLC See Remarks | Grant or award · Warrant (right to purchase) | +705,280 | $13.01 | $9.2M | 705,280 |
| 2024-02-06 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −15,413 | $18.09 | $279K | 462,568 |
| 2024-02-05 | Harris Todd President and CEO | Sale 10b5-1 | −13,817 | $16.97 | $234K | 1,502,697 |
| 2024-02-02 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +25,393 | $0.61 | $15K | 553,374 |
Page 8 of 9 · 170 trades